KH7

• 产品号: K3394
• CAS号: 330676-02-3
• 分子式: C17H15BrN4O2S
• 分子量: 419.2956
• 纯 度: ≥98% (HPLC)

产品别名

• 标题: KH7
• IUPAC标准名: 2-(1H-1,3-benzodiazol-2-ylsulfanyl)-N'-[(5-bromo-2-hydroxyphenyl)methylidene]propanehydrazide
• IUPAC传统名: 2-(1H-1,3-benzodiazol-2-ylsulfanyl)-N'-[(5-bromo-2-hydroxyphenyl)methylidene]propanehydrazide
• 别名: (E)-2-(1H-Benzo[d]imidazol-2-ylthio)-N′-(5-bromo-2-hydroxybenzylidene)propanehydrazide

产品登记号

• MDL号: MFCD01230899
• CAS号: 330676-02-3

产品性质

• Empirical Formula (Hill Notation): C17H15BrN4O2S
• 纯度: ≥98% (HPLC)
• 外观: powder
• 溶解度: DMSO: >20 mg/mL
• GHS警示词: Danger
• GHS危险声明: H301
• 欧盟危险性物质标志: 有毒(Toxic) (T)
• GHS警示性声明: P301 + P310
• RID/ADR: UN 2811 6.1/PG 3
• 危险公开号: 25
• 安全公开号: 45
• 保存温度: 2-8°C
• 联合国危险货物等级: 6.1
• 联合国危险货物编号: 2811
• 联合国危险货物包装类别(PG): 3

产品详细信息

详细说明 (English)

Biochem/physiol Actions
KH7 is a selective inhibitor of soluble adenylyl cyclase. Soluble adenylyl cyclase (sAC) is an ubiquitously expressed, essential component of cAMP-signaling.
Suitability
KH7 is not active against sAC in the presence of detergents. When used in cellular experiments, KH7 exhibits non-specific membrane disruption effects at concentrations above 50 μM.

详细说明 (简体中文)

Biochem/physiol Actions
KH7 is a selective inhibitor of soluble adenylyl cyclase. Soluble adenylyl cyclase (sAC) is an ubiquitously expressed, essential component of cAMP-signaling.
Suitability
KH7 is not active against sAC in the presence of detergents. When used in cellular experiments, KH7 exhibits non-specific membrane disruption effects at concentrations above 50 μM.